Shares of Grail, Inc. (NASDAQ:GRAL - Get Free Report) traded up 6.1% during trading on Wednesday . The company traded as high as $30.46 and last traded at $30.01. 62,489 shares were traded during mid-day trading, a decline of 94% from the average session volume of 1,045,966 shares. The stock had previously closed at $28.28.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on GRAL shares. Wolfe Research assumed coverage on shares of Grail in a research note on Friday, November 15th. They set a "peer perform" rating on the stock. Guggenheim assumed coverage on Grail in a research report on Thursday, October 17th. They issued a "neutral" rating on the stock. Finally, Morgan Stanley assumed coverage on Grail in a research report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 price target for the company.
Check Out Our Latest Research Report on Grail
Grail Price Performance
The company's fifty day moving average is $21.72 and its two-hundred day moving average is $17.17.
Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($3.94) earnings per share for the quarter. The firm had revenue of $28.65 million for the quarter. Analysts expect that Grail, Inc. will post -65.16 earnings per share for the current year.
Insider Activity
In related news, CFO Aaron Freidin sold 30,452 shares of the business's stock in a transaction on Monday, November 18th. The shares were sold at an average price of $14.02, for a total value of $426,937.04. Following the completion of the transaction, the chief financial officer now directly owns 268,277 shares in the company, valued at $3,761,243.54. The trade was a 10.19 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
Institutional Trading of Grail
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Crcm LP purchased a new stake in shares of Grail during the 4th quarter worth about $65,061,000. Bank of New York Mellon Corp purchased a new position in Grail during the fourth quarter worth approximately $6,262,000. TCW Group Inc. acquired a new stake in Grail in the fourth quarter valued at approximately $5,095,000. abrdn plc acquired a new stake in Grail in the fourth quarter valued at approximately $3,768,000. Finally, Douglas Lane & Associates LLC purchased a new stake in shares of Grail in the fourth quarter valued at approximately $3,034,000.
Grail Company Profile
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Further Reading
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
